Theratechnologies inc.
TSX : TH

Theratechnologies inc.

September 18, 2008 14:26 ET

Theratechnologies to Present at UBS Global Life Sciences Conference

MONTREAL, CANADA--(Marketwire - Sept. 18, 2008) - Theratechnologies (TSX:TH) announced today that Yves Rosconi, President and Chief Executive Officer, will present an overview of the Company at the 2008 UBS Global Life Sciences Conference, which will take place next week in New York City. Mr. Rosconi will be speaking at 3:00 p.m., on Tuesday, September 23.

An audio webcast of the presentation will be available live and by replay at the following addresses: www.ibb.ubs.com and www.theratech.com.The replay of the presentation will begin 3 hours after the actual presentation and will be available until October 3, 2008.

About Theratechnologies

Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers innovative drug candidates in order to develop them and bring them to market. The Company targets unmet medical needs in financially attractive specialty markets. Its most advanced program is tesamorelin, now in a confirmatory Phase 3 clinical trial for a serious metabolic disorder known as HIV-associated lipodystrophy. The Company also has other projects at earlier stages of development.

Contact Information